RTW Investments, LP 13D and 13G filings for Fulcrum Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 06:15 am Sale | 2024-09-30 | 13G | FULCRUM THERAPEUTICS INC FULC | RTW Investments, LP | 0 0.000% | -5,469,956 (Position Closed) | Filing |
| 2024-02-14 07:53 am Purchase | 2023-12-31 | 13G | FULCRUM THERAPEUTICS INC FULC | RTW Investments, LP | 5,469,956 8.800% | 476,677 (+9.55%) | Filing |
| 2023-02-14 10:04 am Purchase | 2022-12-31 | 13G | FULCRUM THERAPEUTICS INC FULC | RTW Investments, LP | 4,993,279 9.600% | 1,126,407 (+29.13%) | Filing |
| 2022-02-14 08:22 am Purchase | 2021-12-31 | 13G | FULCRUM THERAPEUTICS INC FULC | RTW Investments, LP | 3,866,872 9.500% | 1,795,463 (+86.68%) | Filing |